BOULDER, CO / ACCESSWIRE / November 14, 2024 / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

About 1 in 8 U.S. adults have taken Ozempic or similar medications used to treat Type 2 diabetes and obesity. While these ...

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves ...

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on fiscal 2024 ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

(Cerullo, 11/13) The Hill: Ozempic And Wegovy May Help With Alcohol Addiction The weight loss drugs Ozempic and Wegovy may ... (Irwin, 11/13) Yahoo Finance: Hims & Hers Launches GLP-1 Tracker In ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.